Literature DB >> 15159655

Juvenile Sandhoff disease--nine new cases and a review of the literature.

C J Hendriksz1, P C Corry, J E Wraith, G T N Besley, A Cooper, C D Ferrie.   

Abstract

Juvenile Sandhoff disease (McKusick 268800) is a rare lysosomal storage disorder with only 12 cases recorded in the literature. This condition is also referred to as the subacute form of hexosaminidase deficiency. We describe 9 new cases of Pakistani origin and compare these with the other published cases. Ataxia and speech abnormalities were the commonest presentation. Constipation and urinary incontinence were frequent and may be due to autonomic neuropathy. Cherry-red spot was not noted in any of our cases. Increased lower limb reflexes were the commonest physical finding. Significant delay in diagnosis may be due to the nonspecific presentation of this condition. Diagnosis was on the basis of hexosaminidase deficiency. Residual enzyme activity did not correlate with the clinical picture. Emerging therapies make early diagnosis of this disorder important.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15159655     DOI: 10.1023/B:BOLI.0000028777.38551.5a

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  10 in total

1.  Peripheral and autonomic nervous system involvement in chronic GM2-gangliosidosis.

Authors:  M S Salman; J T Clarke; G Midroni; M B Waxman
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

2.  Juvenile Sandhoff disease.

Authors:  A G Unnikrishnan; S Danda; M S Seshadri
Journal:  Indian Pediatr       Date:  2001-01       Impact factor: 1.411

3.  Progressive cerebellar ataxia in juvenile GM2-gangliosidosis type Sandhoff.

Authors:  M Beck; N Sieber; H H Goebel
Journal:  Eur J Pediatr       Date:  1998-10       Impact factor: 3.183

4.  Psychiatric features of adult GM2 gangliosidosis.

Authors:  J Streifler; M Golomb; N Gadoth
Journal:  Br J Psychiatry       Date:  1989-09       Impact factor: 9.319

5.  Juvenile Sandoff disease: report of an additional case with family studies.

Authors:  S Wood; D A Applegarth
Journal:  Monogr Hum Genet       Date:  1978

6.  Late-onset GM2 gangliosidosis presenting as burning dysesthesias.

Authors:  G C Chow; J T Clarke; B L Banwell
Journal:  Pediatr Neurol       Date:  2001-07       Impact factor: 3.372

7.  [Juvenile Sandhoff disease with local panatrophy--a case report].

Authors:  R Nakano; N Wakamatsu; S Tsuji; G Matsumura; T Miyatake
Journal:  Rinsho Shinkeigaku       Date:  1989-08

8.  [A case of juvenile Sandhoff disease].

Authors:  K Mitsuo; N Koutake; T Kobayashi; H Iwashita; I Goto
Journal:  Rinsho Shinkeigaku       Date:  1990-02

9.  Late-onset hexosaminidase A and hexosaminidase A and B deficiency: family study and review.

Authors:  C Adams; S Green
Journal:  Dev Med Child Neurol       Date:  1986-04       Impact factor: 5.449

10.  Progressive cerebellar ataxia, spasticity, psychomotor retardation, and hexosaminidase deficiency in a 10-year-old child: juvenile Sandhoff disease.

Authors:  P M MacLeod; S Wood; J E Jan; D A Applegarth; C L Dolman
Journal:  Neurology       Date:  1977-06       Impact factor: 9.910

  10 in total
  9 in total

Review 1.  The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.

Authors:  Gustavo H B Maegawa; Tracy Stockley; Michael Tropak; Brenda Banwell; Susan Blaser; Fernando Kok; Roberto Giugliani; Don Mahuran; Joe T R Clarke
Journal:  Pediatrics       Date:  2006-10-02       Impact factor: 7.124

2.  Clinical,biochemical and molecular analysis of five Chinese patients with Sandhoff disease.

Authors:  Wen Zhang; Huasong Zeng; Yonglan Huang; Ting Xie; Jipeng Zheng; Xiaoyuan Zhao; Huiying Sheng; Hongsheng Liu; Li Liu
Journal:  Metab Brain Dis       Date:  2016-03-28       Impact factor: 3.584

3.  Emerging links between pediatric lysosomal storage diseases and adult parkinsonism.

Authors:  Daniel Ysselstein; Joshua M Shulman; Dimitri Krainc
Journal:  Mov Disord       Date:  2019-02-06       Impact factor: 10.338

4.  A case report of Sandhoff disease.

Authors:  R Saouab; M Mahi; R Abilkacem; H Boumdin; S Chaouir; O Agader; T Amil; A Hanine
Journal:  Clin Neuroradiol       Date:  2010-12-10       Impact factor: 3.649

5.  Circadian profiling in two mouse models of lysosomal storage disorders; Niemann Pick type-C and Sandhoff disease.

Authors:  Katie Richardson; Achilleas Livieratos; Richard Dumbill; Steven Hughes; Gauri Ang; David A Smith; Lauren Morris; Laurence A Brown; Stuart N Peirson; Frances M Platt; Kay E Davies; Peter L Oliver
Journal:  Behav Brain Res       Date:  2015-10-20       Impact factor: 3.332

6.  Hexb enzyme deficiency leads to lysosomal abnormalities in radial glia and microglia in zebrafish brain development.

Authors:  Laura E Kuil; Anna López Martí; Ana Carreras Mascaro; Jeroen C van den Bosch; Paul van den Berg; Herma C van der Linde; Kees Schoonderwoerd; George J G Ruijter; Tjakko J van Ham
Journal:  Glia       Date:  2019-05-29       Impact factor: 7.452

7.  Homozygous variants in the HEXB and MBOAT7 genes underlie neurological diseases in consanguineous families.

Authors:  Shazia Khan; Lettie E Rawlins; Gaurav V Harlalka; Muhammad Umair; Asmat Ullah; Shaheen Shahzad; Muhammad Javed; Emma L Baple; Andrew H Crosby; Wasim Ahmad; Asma Gul
Journal:  BMC Med Genet       Date:  2019-12-18       Impact factor: 2.103

8.  Incidence rates of progressive childhood encephalopathy in Oslo, Norway: a population based study.

Authors:  Petter Stromme; Oivind Juris Kanavin; Michael Abdelnoor; Berit Woldseth; Terje Rootwelt; Jorgen Diderichsen; Bjorn Bjurulf; Finn Sommer; Per Magnus
Journal:  BMC Pediatr       Date:  2007-06-27       Impact factor: 2.125

Review 9.  Lipophagy and Lipolysis Status in Lipid Storage and Lipid Metabolism Diseases.

Authors:  Anna Kloska; Magdalena Węsierska; Marcelina Malinowska; Magdalena Gabig-Cimińska; Joanna Jakóbkiewicz-Banecka
Journal:  Int J Mol Sci       Date:  2020-08-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.